| 词条 | SLC26A2 |
| 释义 |
The SLC26A2 protein is a member of the solute carrier family. In humans, this transporter is encoded by the SLC26A2 gene.[1] SLC26A2 is also called the diastrophic dysplasia sulfate transporter (DTDST), and was first described by Hästbacka et al in 1994.[1] This sulfate (SO42−) transporter also accepts chloride, hydroxyl ions (OH-), and oxalate as substrates.[2][3] SLC26A2 is expressed at high levels in developing and mature cartilage, as well as being expressed in lung, placenta, colon, kidney, pancreas and testis.[4][6] FunctionThe diastrophic dysplasia sulfate transporter is a transmembrane glycoprotein implicated in the pathogenesis of several human chondrodysplasias. In chondrocytes, SLC26A2 functions to transport most of the cellular sulfate, which is critical for the sulfation of proteoglycans and normal cartilage formation.[5] In addition, studies have demonstrated that SLC26A2 influences chondrocyte proliferation, differentiation, and growth, suggesting that in chondrocyte, SLC26A2 provides sulfate for both structural and regulatory proteins.[6] Clinical significanceDeficiencies are associated with many forms of osteochondrodysplasia.[7] These include:
Correlation between genotype and phenotype:Since its first description, over 30 mutations in the SLC26A2 gene have been described in the four recessively inherited chondrodysplasias listed above. Achondrogenesis 1B (ACG-1B) is the most severe form of these chondrodysplasias, resulting in skeletal underdevelopment and death preceding or shortly after birth.[8] Atelosteogenesis type II (AO-II) can be lethal in the neonatal period,[9] whereas diastrophic dysplasia (DTD) and autosomal recessive multiple epiphyseal dysplasia (EDM4/rMED) are considered to be the least severe forms. When ten previously described SLC26A2 mutation were expressed in mammalian cells, a strong correlation was found between the amount of sulfate transport activity of the mutated protein and the severity of the phenotype in patients where these mutations have been identified.[10] For example, a mutation that results in a non-functional protein on both alleles was always found with the severe ACG-IB phenotype, but non-functional mutations on both alleles were never found with the less severe phenotypes, DTD and rMED. Mutations found in the moderately severe AO-II phenotype were always the result of a non-functioning mutation on one allele and a partial-functioning mutation on the opposite allele. In contrast, mutations described in the mildest form of the chondrodysplasia, rMED, result in proteins that retains at least some partial sulfate transport function on both alleles. This suggests that even a small amount of SLC26A2-mediated sulfate transport in chondrocytes can mitigate the clinical severity of the chondrodysplasia. However, a less predictable genotype/phenotype correlation has been found with a mutation described predominately in the Finnish population. This Finnish mutation is located in the splice site of the gene and results in low SLC26A2 mRNA levels.[11] Different levels of expression of the SLC26A2 protein is probably the cause of the variable phenotypes described with this mutation. Functional significance of SLC26A2 in the colon and the kidneyImmunohistochemical analysis has localized SLC26A2 to the apical membrane of colon epithelial cells and kidney proximal tubule cells.[2][12] Colon:Abundant SLC26A2 mRNA levels have been identified in the small and large intestine of mice, rats and humans. In the human colon, SLC26A2 is present in the upper third of the crypts, where it is directed toward the apical membrane.[13] The physiological role of SLC26A2 in the human colon remains to be determined, but it likely represent the sulfate/oxalate exchanger that has been characterized in colonic apical membrane vesicle preparations and possibly plays an important role in sulfate transport in this tissue.[14] In fact, impaired sulfation has been suggested to occur during the course of malignant transformation of colonic epithelial cells, and studies have shown that the growth rate of cancer cells was markedly enhanced when the transcription of SLC26A2 was suppressed.[15] Kidney:The SLC26A2 protein has been localized to the brush border membrane of the rat kidney proximal tubule.[12] In that location, oxalate/SO42− exchange, or chloride/SO42− exchange by SLC26A2 might contribute to the critical process of sodium chloride reabsorption across the proximal tubular epithelium. Under one proposed model, an anion transporter exchanges intracellular oxalate for luminal chloride in parallel with the Na–SO4 cotransporter, resulting in net sodium chloride readsorption.[16] Under this model, a third transport process is required that functions as a method of recycling oxalate back into the cell, and recycling sulfate from the cell to the lumen. Previously, SLC26A6, another member of the same family of anion transporters as DTDST, was thought to provide the mechanism of oxalate- or formate-mediated chloride transport in this nephron segment; however, recent studies in Slc26a6-knockout mice have raised questions regarding its role in this transport process.[17] In contrast, the apical membrane location, and electrochemical properties, of SLC26A2 would fit the requirement of an anion exchanger located on the apical membrane of the proximal tubule that would serve as a mechanism of transporting chloride in exchange for oxalate, and/or recycling oxalate in exchange for sulfate. References1. ^1 {{cite journal | vauthors = Hästbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, Daly M, Hamilton BA, Kusumi K, Trivedi B, Weaver A | title = The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping | journal = Cell | volume = 78 | issue = 6 | pages = 1073–87 | date = September 1994 | pmid = 7923357 | doi = 10.1016/0092-8674(94)90281-X }} 2. ^1 {{cite journal | vauthors = Heneghan JF, Akhavein A, Salas MJ, Shmukler BE, Karniski LP, Vandorpe DH, Alper SL | title = Regulated transport of sulfate and oxalate by SLC26A2/DTDST | journal = American Journal of Physiology. Cell Physiology | volume = 298 | issue = 6 | pages = C1363-75 | date = June 2010 | pmid = 20219950 | doi = 10.1152/ajpcell.00004.2010 }} 3. ^{{cite journal | vauthors = Ohana E, Shcheynikov N, Park M, Muallem S | title = Solute carrier family 26 member a2 (Slc26a2) protein functions as an electroneutral SOFormula/OH-/Cl- exchanger regulated by extracellular Cl- | journal = The Journal of Biological Chemistry | volume = 287 | issue = 7 | pages = 5122–32 | date = February 2012 | pmid = 22190686 | doi = 10.1074/jbc.M111.297192 | url = http://www.jbc.org/lookup/doi/10.1074/jbc.M111.297192 }} 4. ^{{cite journal | vauthors = Haila S, Hästbacka J, Böhling T, Karjalainen-Lindsberg ML, Kere J, Saarialho-Kere U | title = SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types | journal = The Journal of Histochemistry and Cytochemistry | volume = 49 | issue = 8 | pages = 973–82 | date = August 2001 | pmid = 11457925 | doi = 10.1177/002215540104900805 }} 5. ^{{cite web|url=https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1836|title=Entrez Gene: SLC26A2|access-date=}} 6. ^{{cite journal | vauthors = Park M, Ohana E, Choi SY, Lee MS, Park JH, Muallem S | title = Multiple roles of the SO4(2-)/Cl-/OH- exchanger protein Slc26a2 in chondrocyte functions | journal = The Journal of Biological Chemistry | volume = 289 | issue = 4 | pages = 1993–2001 | date = January 2014 | pmid = 24302720 | doi = 10.1074/jbc.M113.503466 }} 7. ^1 {{cite journal | vauthors = Forlino A, Piazza R, Tiveron C, Della Torre S, Tatangelo L, Bonafè L, Gualeni B, Romano A, Pecora F, Superti-Furga A, Cetta G, Rossi A | title = A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype | journal = Human Molecular Genetics | volume = 14 | issue = 6 | pages = 859–71 | date = March 2005 | pmid = 15703192 | doi = 10.1093/hmg/ddi079 }} 8. ^{{cite journal | vauthors = Superti-Furga A, Hästbacka J, Wilcox WR, Cohn DH, van der Harten HJ, Rossi A, Blau N, Rimoin DL, Steinmann B, Lander ES, Gitzelmann R | title = Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene | journal = Nature Genetics | volume = 12 | issue = 1 | pages = 100–2 | date = January 1996 | pmid = 8528239 | doi = 10.1038/ng0196-100 }} 9. ^{{cite journal | vauthors = Hästbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES | title = Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias | journal = American Journal of Human Genetics | volume = 58 | issue = 2 | pages = 255–62 | date = February 1996 | pmid = 8571951 | pmc = 1914552 }} 10. ^{{cite journal | vauthors = Karniski LP | title = Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells | journal = Human Molecular Genetics | volume = 13 | issue = 19 | pages = 2165–71 | date = October 2004 | pmid = 15294877 | doi = 10.1093/hmg/ddh242 }} 11. ^{{cite journal | vauthors = Hästbacka J, Kerrebrock A, Mokkala K, Clines G, Lovett M, Kaitila I, de la Chapelle A, Lander ES | title = Identification of the Finnish founder mutation for diastrophic dysplasia (DTD) | journal = European Journal of Human Genetics | volume = 7 | issue = 6 | pages = 664–70 | date = September 1999 | pmid = 10482955 | doi = 10.1038/sj.ejhg.5200361 }} 12. ^1 {{cite journal | vauthors = Chapman JM, Karniski LP | title = Protein localization of SLC26A2 (DTDST) in rat kidney | journal = Histochemistry and Cell Biology | volume = 133 | issue = 5 | pages = 541–7 | date = May 2010 | pmid = 20369363 | doi = 10.1007/s00418-010-0694-x }} 13. ^{{cite journal | vauthors = Haila S, Saarialho-Kere U, Karjalainen-Lindsberg ML, Lohi H, Airola K, Holmberg C, Hästbacka J, Kere J, Höglund P | title = The congenital chloride diarrhea gene is expressed in seminal vesicle, sweat gland, inflammatory colon epithelium, and in some dysplastic colon cells | journal = Histochemistry and Cell Biology | volume = 113 | issue = 4 | pages = 279–86 | date = April 2000 | pmid = 10857479 }} 14. ^{{cite journal | vauthors = Tyagi S, Kavilaveettil RJ, Alrefai WA, Alsafwah S, Ramaswamy K, Dudeja PK | title = Evidence for the existence of a distinct SO(4)(--)-OH(-) exchange mechanism in the human proximal colonic apical membrane vesicles and its possible role in chloride transport | journal = Experimental Biology and Medicine | volume = 226 | issue = 10 | pages = 912–8 | date = November 2001 | pmid = 11682697 }} 15. ^{{cite journal | vauthors = Yusa A, Miyazaki K, Kimura N, Izawa M, Kannagi R | title = Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells | journal = Cancer Research | volume = 70 | issue = 10 | pages = 4064–73 | date = May 2010 | pmid = 20460514 | doi = 10.1158/0008-5472.CAN-09-2383 }} 16. ^{{cite journal | vauthors = Kuo SM, Aronson PS | title = Pathways for oxalate transport in rabbit renal microvillus membrane vesicles | journal = The Journal of Biological Chemistry | volume = 271 | issue = 26 | pages = 15491–7 | date = June 1996 | pmid = 8663096 }} 17. ^{{cite journal | vauthors = Knauf F, Velazquez H, Pfann V, Jiang Z, Aronson PS | title = -/- mice | journal = American Journal of Physiology. Renal Physiology | volume = 316 | issue = 1 | pages = F128-F133 | date = January 2019 | pmid = 30427220 | pmc = 6383200 | doi = 10.1152/ajprenal.00309.2018 }} Further reading{{refbegin | 2}}
External links{{refbegin}}
1 : Solute carrier family |
| 随便看 |
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。